Immunology: The Cornerstone of Future, Personalized Medicine
MADRID, 25 Sep. 2025 (Europa Press) – Silvia Sánchez-ramón, Head of Clinical Immunology at Ruber International Hospital, advocates for investment in translational research centers to ensure the safe, equitable, and sustainable implementation of advanced laboratory therapies. She highlighted the pivotal role of immunology in groundbreaking treatments like CAR-T cell therapy, which has transformed cancer treatment and is now being investigated for severe autoimmune diseases.Emerging therapies utilizing tumor-infiltrating lymphocytes (TIL) also show promise against solid tumors and chronic illnesses.
Sánchez-ramón emphasized that immunology provides the “basic architecture” for a future medicine focused on precision,humanization,and integration. This shift will move healthcare from a reactive approach to a more proactive and preventative model.
Key to this evolution will be the growth of highly accurate biomarkers capable of detecting immunological changes before the onset of symptoms, making early diagnosis a standard practice.
Artificial intelligence (AI) is identified as a crucial strategic partner in this endeavor. AI’s ability to analyze vast datasets of genetic and immunological information will enable more reliable predictions, freeing up physician time for more focused and compassionate patient care.
Sánchez-Ramón stressed that accomplished advancement in immunology requires robust multidisciplinary collaboration, bringing together experts in immunology, oncology, rheumatology, internal medicine, bioinformatics, and pharmacology.
“Immunology will be decisive in achieving personalized,preventative,and predictive medicine,” Sánchez-Ramón stated. “But its greatest strength lies in its inherent focus on the patient – combining scientific rigor with genuine human care.”
